---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-26-000008"
form_type: "8-K"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:43:48.407680+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Director Yoshiaki Fujimori will not stand for re-election at Boston Scientific's 2026 annual meeting

## Summary
- Yoshiaki Fujimori informed Boston Scientific on Feb 2, 2026, that he will not seek re-election.
- Fujimori has served on the Board since July 2016 and chairs the Risk, Science and Technology Committee.
- He will continue as director and committee chair until the 2026 Annual Meeting.
- Departure is not due to any disagreement with the company; Board will evaluate potential replacements.
- The Nominating and Governance Committee will consider adding directors to the Board after his departure.

## SEC filing metadata
- accession: 0000885725-26-000008
- form_type: 8-K
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572526000008/0000885725-26-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572526000008/bsx-20260202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-26-000008
- JSON: https://secwatch.observer/filing/0000885725-26-000008.json
- Plain text: https://secwatch.observer/filing/0000885725-26-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.